Cara Therapeutics

Cara Therapeutics Inc., a Tarrytown, N.Y.-based biotech company focused on pain and inflammation, has raised $5 million in additional Series C funding, to close out the round at $24 million. It had announced the $19 million first tranche last November. Scottish Windows and Mitsubishi provided the new capital, while the initial Series C backers included MVM Life Science Partners, Alta Partners and Ascent Biomedical Ventures. www.caratherapeutics.com